SUMMARYFrom 1979 to August 1987, there have been 178 cases of meningococcal disease in Iquique, Chile, a city of about 140000. The attack rate for the last 5 years has been in excess of 20/100000 per year, more than 20 times greater than for the country overall. The mortality rate was 6 %. The disease occurred in patients with ages from 4 months to 60 years, but 89 % of cases were in patients < 21 years. The largest number of cases were in the age group 5-9 years (n = 54), but the highest incidence occurred in children less than 1 year of age (72-8/100000 per year). The male/female ratio was 1-2. Cases occurred all year round with little seasonal variation. Of the 178 cases, 173 were biologically confirmed. Serogroup analysis of strains from 135 patients revealed A = 1, B = 124, C = 10. Forty-four group B strains from 1985-7 were serotyped: 15:P1.3 = 36, 15:NT = 4, 4:P1.3 = 2, NT: NT = 2. Ten of 11 of the outbreak strains tested were sulfadiazine-resistant. This is the first recognized outbreak caused by a Gp B: 15 strain in South America. It shares many of the characteristics of outbreaks caused by closely related strains in Europe, such as a predilection for older children and adolescents, sulfadiazineresistance, and sustained high attack rates. The Iquique strain (B:15: P1.3) belongs to the same genetic clone (ET-5 complex) as the Norway (B: 15: PI. 16) and the Cuban (B :4: P1. 15) strains.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.